3,800+ Verified Global Buyers of Indian Pharmaceuticals & APIs

USA (30% of India's pharma exports), UK (9%), South Africa (8%), Nigeria (6%), Kenya (5%), Germany (4%). Indian companies like Sun Pharma, Dr. Reddy's, Cipla supply 47% of all generic medicines used in the USA. EximHub has buyer contacts at McKesson, Cardinal Health, AmerisourceBergen, and 3,800+ more.

US FDA ANDA (Abbreviated New Drug Application) for USA. EU GMP certificate from EMA for Europe. MHRA approval for UK. WHO-GMP certificate (issued by CDSCO) for developing countries. Schedule M compliance + COPP certificate mandatory for all exports. Most buyers also require DMF (Drug Master File) for APIs.

EximHub provides direct contacts for 3,800+ pharma importers across 200 countries. Key targets: pharmaceutical wholesalers (McKesson USA, Alliance UK), government procurement agencies (UNICEF, Global Fund), hospital chains, and retail pharmacy chains in Gulf and Africa. Average order size: $50,000–$500,000 per shipment.

Retail-pack generics: 10,000–50,000 units per SKU. Bulk API export: 100 KG–1 MT minimum. Hospital supply tenders: typically $25,000+ per order. Africa/developing market buyers often accept smaller trial orders (5,000–10,000 units) for new supplier qualification.